Abstract:Nurse‐led renal cell cancer follow up is a safe, reliable and effective clinical framework that has significant benefits in regard to resource utilization. USS and CXR are ineffective in detecting recurrence and CT should be considered the imaging modality of choice for this purpose. Background In 2015 our centre introduced a nurse‐led renal cell cancer follow‐up protocol and clinic for patients who have undergone partial or radical nephrectomy for organ‐confined kidney tumours. The main aims of this clinic were to improve healthcare efficiency and standardize follow‐up processes. Objectives The primary objective was to assess the effectiveness of a nurse‐led renal cell cancer follow up clinic in regard to surveillance protocol compliance and the timely identification and appropriate management of recurrences. A secondary objective was to evaluate this locally developed follow up protocol against the current European Association of Urology (EAU) guidelines surveillance protocol. Patient and Methods All patients who underwent a partial or radical nephrectomy between 2015 and 2021 at a single Western Australia institution for a primary renal malignancy were included. Data was collected from local clinical information systems and protocol adherence, recurrence characteristics and management were assessed. The current EAU guidelines were applied to the cohort to assess differences in risk‐stratification and theoretical outcomes between the protocols. Results After a mean follow up period of 31.2 months (range 0–77 months), 75.5% (185/245) of patients had all follow up imaging and reviews within 1 month of the timeframe scheduled on the protocol. 17.1% (42/245) had a delay in their follow up of more than a month at some stage, 5.7% (14/245) did not attend for follow up but had documented attempts to facilitate their compliance, and 0.4% (1/245) were lost to follow up with no evidence of attempted contact. 15.5% (38/245) of patients had recurrence of malignancy detected during follow up and these were all discussed in a multi‐disciplinary team (MDT) meeting. The recurrence rate was 2.5% (3/119) for low risk, 17.7% (14/79) for intermediate risk, and 44.7% (21/47) for high risk patients when they were re‐stratified according to EAU risk categories. No recurrences were detected through ultrasound (USS) or chest x‐ray (CXR) in this cohort and our protocol tended to place patients in higher risk‐stratification groups as compared to current EAU guidelines. Conclusion Nurse‐led renal cell cancer follow up is a safe, reliable and effective clinical framework that has significant benefits in regard to resource utilization. USS and CXR are ineffective in detecting recurrence and Computerized tomography (CT) should be considered the imaging modality of choice for this purpose. The EAU surveillance protocol appears superior to our protocol, and we have therefore transitioned to the EAU guideline protocol going forward.

Development of a new radical cystectomy surveillance protocol and nurse‐led cystectomy follow‐up clinic in Australia

Nurse‐led renal cell carcinoma clinic: a single center review

Survival after Radical Cystectomy for Bladder Cancer: Multicenter Comparison Between Minimally Invasive and Open Approaches

Radical Cystectomy in England from 2013 to 2019 on 12,644 patients: An analysis of national trends and comparison of surgical approaches using Hospital Episode Statistics data

National Surgical Quality Improvement Program audit of contemporary perioperative care for radical cystectomy

Clinical Outcomes of Pelvic Lymph Node Dissection Before Versus after Robot-Assisted Laparoscopic Radical Cystectomy

The Role of Radical Cystectomy in Clinically Node Positive Bladder Cancer: A US Veterans Health Administration Study

Defining Factors Associated with High-quality Surgery Following Radical Cystectomy: Analysis of the British Association of Urological Surgeons Cystectomy Audit

Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels

Annual trends of cystectomy complications: A contemporary analysis of the NSQIP database

Operative management and outcomes of gallbladder cancer in Australia: a multi‐institutional, retrospective, observational cohort analysis

Prospective Implementation of Enhanced Recovery After Surgery Protocols to Radical Cystectomy

A comparative analysis of radical cystectomy with perioperative chemotherapy, chemoradiation therapy, or systemic therapy in patients with clinically advanced node-positive bladder cancer (cN2/N3)

Initial experiences with the enhanced recovery after surgery (ERAS) protocol in open radical cystectomy

Variation in Follow-Up after Radical Cystectomy for Bladder Cancer—An Inventory Roundtable and Literature Review

Impact of Enhanced Recovery after Surgery® Protocol Compliance on Length of Stay, Bowel Recovery and Complications after Radical Cystectomy

Perioperative and Complication-Related Outcomes for Robotic-Assisted versus Open Radical Cystectomy: A Comparative NSQIP Analysis

Standardisation of perioperative urinary catheter use to reduce postsurgical urinary tract infection: an interrupted time series study

Postoperative complications and hospital costs following open radical cystectomy: A retrospective study

Implementation of enhanced recovery after surgery in patients undergoing radical cystectomy: A retrospective cohort study